Effects of nitric oxide synthase inhibition or sulfasalazine on the spontaneous colitis observed in HLA-B27 transgenic rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 284, Issue 2, 1998, Pages 722-727

  Aiko, Satoshi ^a   Fuseler, John ^a   Grisham, Matthew B ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; EDETIC ACID; HLA B27 ANTIGEN; MYELOPEROXIDASE; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; SALAZOSULFAPYRIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INFILTRATION; CHROMIUM 51 RELEASE; COLITIS; CONTROLLED STUDY; ENZYME INHIBITION; INTESTINE MUCOSA PERMEABILITY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; TRANSGENIC MOUSE;

EID: 0031910270     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Aiko S, Davis J, Benoit JN and Grisham MB ( 1995) Effects of acute and chronic NOS inhibition on splanchnic organ blood flow: Implications in gut and liver pathophf iology. Gastroenterology 108:A268.
2. Aiko S and Grisham MB (1995) Spontaneous intestinal inflammation and nitric oxide metabolism in HLA-B27 transgenic rats. Gastroenterology 109:142-150.
3. Beauvais F, Michel L and Dubertret L (1995) Exogenous nitric oxide elicits chemotaxis of neutrophils in vitro. J Cell Physiol 165:610-614.
4. Boughton-Smith NK, Evans SM, Hawkey CJ, Cole AT, Balsitis M, Whittle BJR and Moncada S (1993) Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet 342: 338-340.
5. Brownlee M, Vlassara H, Kooney A, Ulrich P and Cerami A (1986) Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 240:1629-1632.
6. Corbett JA, Tilton RG, Chang K, Hasan KS, Ido Y, Wang JL, Sweetland MA, Lancaster JE, Williamson JR and McDaniel ML (1992) Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 41:552-556.
7. Cross AH, Misko TP, Lin RF, Hickey WF, Trotter JL and Tilton RG (1994) Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in Sjl mice. J Clin Invest 93:2684-2690.
8. Granger DN, Grisham MB and Kvietys PR (1994) Mechanisms of microvascular injury, in Physiology of the Gastrointestinal Tract (Johnson LR ed), Raven Press, pp 1693-1722.
9. Griffiths MJD, Messent M, MacAllister RJ and Evans TW (1993) Aminoguanidine selectivity inhibits inducible nitric oxide synthase. Br J Pharmacol 110:963-968.
10. Grisham MB, DeMichele SJ, Garleb KA and Specian RD (1996) Sulfasalazine or enteral diets containing fish oil or oligosaccharides attenuate chronic colitis in rats. Inflamm Bowel Dis 2:178-188.
11. Grisham MB, Johnson GG and Lancaster JRJ (1996) Quantitation of nitrate and nitrite in extracellular fluids. Methods Enzymol 268:237-246.
12. Grisham MB, Specian RD and Zimmerman TE (1994) Effects of nitric oxide synthase inhibition on the pathophysiology observed in a model of chronic granulomatous colitis. J Pharm Exp Ther 271:1114-1121.
13. Hogaboam CM, Jacobson K, Collins SM and Blennerhassett MG (1995) The selective beneficial effects of nitric oxide inhibition in experimental colitis. Am J Physiol 268:G673-G684.
14. G-monomethyl-L-arginine: A role for cyclic GMP. Blood 74:1885-1887.
15. Kubes P (1993) Ischemia-reperfusion in feline small intestine: a role for nitric oxide. Am J Physiol 264:G143-G149.
16. Kumari K, Umar S, Bansal V and Sahib MK (1991) Monoaminoguanidine inhibits aldose reductase. Biochem Pharmacol 4:1527-1528.
17. Lander HM, Jacovina AT, Davis RJ and Tauras JM (1996) Differential activation of mitogen-activated protein kinases by nitric oxide-related species. J Biol Chem 271:19705-19709.
18. Laszlo F, Whittle BJR and Moncada S (1994) Time-dependent enhancement or inhibition of endotoxin-induced vascular injury in rat intestine by nitric oxide synthase inhibitors. Br J Pharmacol 111:1309-1315.
19. Lindell SE, Nilsson K, Roos B-E and Westling H (1960) The effect of enzyme inhibitors on histamine catabolism in man. Br J Pharmacol 15:351-355.
20. Lundberg JON, Hellstrom PM, Lundberg JM and Alving K (1994) Greatly increased luminal nitric oxide in ulcerative colitis. Lancet 1:1673-1674.
21. Mebmer UK, Lapetina EG and Brune B (1995) Nitric oxide-induced apoptosis in RAW 264.7 macrophages is antagonized by protein kinase C- and protein kinase A-activating compounds. Mol Pharmacol 47:757-765.
22. Mebmer UK, Reed JC and Brune B (1996) Bcl-2 protects macrophages from nitric oxide-induced apoptosis. J Biol Chem 271:20192-20197.
23. Middleton SJ, Shorthouse M and Hunter JO (1993) Increased nitric oxide synthesis in ulcerative colitis. Lancet 1:465-466.
24. Miles AM and Grisham MB (1994) Antioxidant properties of aminosalicylates. Methods Enzymol 234:555-572.
25. Miller MJS, Sadowska-Krowicka H, Chotinaruemol S, Kakkis JL and Clark DA (1993) Amelioration of chronic ileitis by nitric oxide synthase inhibition. J Pharm Exp Ther 264:11-16.
26. Miller MJS, Zhang XJ, Sadowska-Krowicka H, Chotinaruemol S, McIntyre JA, Clark DA and Butamonte SA (1993) Nitric oxide release in response to gut injury. Scand J Gastroenterol 28:149-154.
27. Picard S, Parthasarathy S, Fruebis J and Witzum JL Aminoguanidine inhibits oxidative modification of low density lipoprotein protein and the subsequent increase in uptake by macrophage scavenger receptors. Proc Natl Acad Sci USA 89:6876-6880.
28. Rachmilewitz D, Stamler JS, Bachwich D, Karmeli F, Ackerman Z and Podolsky DK (1995) Enhanced colonie nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Gut 36:718-723.
29. Ribbons KA, Currie MG, Conner JR, Manning PT, Allen PC, Didier P, Ratteree MS, Clark DA and Miller MJS (1997) The effect of inhibitors of inducible nitric oxide synthase on chronic colitis in the rhesus monkey. J Pharm Exp Ther 280:1008-1015.
30. Ruetten H and Thiemermann C (1996) Prevention of the expression of inducible nitric oxide synthase by aminoguanidine or aminoethyl-isothiourea in macrophages and in the rat. Biochem Biophys Res Commun 225:525-530.
31. Sandoval M, Liu X, Oliver PD, Zhang XJ, Clark DA and Miller MJS (1995) Nitric oxide induces apoptosis in a human colonie epithelial cell line T84. Med Inflamm 4:248-250.
32. Schmidt K, Amstad P, Cerutti P and Baeuerle P (1995) The roles of hydrogen peroxide and Superoxide as messengers in the activation of transcription factor NF-kB. Chem Biol 2:13-22.
33. Schreck R, Rieber P and Baeuerle PA (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kB transcription factor and HIV-1. EMBO J 10:2247-2258.
34. Sen CK and Packer L (1996) Antioxidant and redox regulation of gene transcription. FASEB J 10:709-720.
35. Sherman MP, Aeberhard EE, Wong VZ, Griscavage JM and Ignarro LJ (1993) Pyrrolidine dithiocarbamate inhibits induction of nitric oxide synthase activity in rat alveolar macrophages. Biochem Biophys Res Commun 191:1301-1308.
36. Tepperman BL, Brown JF and Whittle BJR (1993) Nitric oxide synthase induction and intestinal epithelial cell viability in rats. Am J Physiol 265:G214-G218.
37. Valentine JF, Belcaster GM, Stevenot SA and Nick HS (1995) Mesalamine induction of MnSOD: A new mechanism of 5-ASA action. Gastroenterology 108:A933.
38. Villarete LH and Remick DG (1995) Nitric oxide regulation of IL-8 expression in human endothelial cells. Biochem Biophys Res Commun 211:671-676.
39. Wolff DJ and Lubeskie A (1995) Aminoguanidine is an isoform-selective, mechanism-based inactivator of nitric oxide synthase. Arch Biochem Biophys 316:290-301.
40. Xie K, Huang S, Dong Z and Fidler IJ (1993) Cytokine-induced apoptosis in transformed murine fibroblasts involves synthesis of endogenous nitric oxide. Int J Oncol 3:1043-1048.
41. Yamada T, Sartor RB, Marshall S, Specian RD and Grisham MB (1993) Mucosal injury and inflammation in a model of granulomatous colitis in rats. Gastroenterology 104:759-771.